Cargando…
Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
We report the fourth described case of severe toxic rhabdomyolysis occurring in an 81-year-old woman caused by the concomitant administration of palbociclib taken at the usual dosage (125 mg per day) and simvastatin. To the best of our knowledge, this is the first reported case successfully treated...
Autores principales: | Poumeaud, François, Fontanier, Anna, Dion, Jérémie, Mathevet, Quentin, Cointault, Olivier, Uro-Coste, Emmanuelle, Marty, Céline, Dalenc, Florence, Girardie, Pierre, Rataboul, Anaïs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795206/ https://www.ncbi.nlm.nih.gov/pubmed/36591506 http://dx.doi.org/10.3389/fonc.2022.1026434 |
Ejemplares similares
-
Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report
por: Poumeaud, François, et al.
Publicado: (2023) -
Palbociclib in combination with simvastatin induce severe rhabdomyolysis: a case report
por: Nersesjan, Vardan, et al.
Publicado: (2019) -
Simvastatin: Rhabdomyolysis: case report
Publicado: (2020) -
Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib
por: Nelson, Kellie Lynn, et al.
Publicado: (2017) -
Sitagliptin and Simvastatin Interaction Causing Rhabdomyolysis and AKI
por: Patel, Chinmay, et al.
Publicado: (2019)